Understanding differences among preparations and dilutions of botulinum toxin type A can improve clinical practice, according to industry experts.
Collective results from the SAKURA phase 3 clinical trial program investigating daxibotulinumtoxinA for injection for the treatment of moderate-to-severe glabellar lines show that the neuromodulator provides generally safe and long-lasting results.
It’s known that combination therapies can be used to create ideal treatment outcomes, but according to Dr. Suneel Chilukuri, results may also last longer than originally thought.
Dr. Brian Biesman sits down with Dermatology Times to talk about the important role surgery plays in eyelid rejuvenation.
Millennials think of aesthetic treatments no differently than other beauty appointments, according to Dr. Ava Shamban. These are their top facial concerns.
In the evolution of skin resurfacing technology, from full-field CO2 to fractional and now fractional plasma, Alma believes theirs is a novel innovation offering versatile skin solutions.
Investigative cryolipolysis technique holds promise as a new strategy for selective, nonsurgical fat reduction.
In his presentation at the current Maui Derm 2020, Dr. Curtis Cole tackled the controversy of how SPF labeling can differ significantly from the actual protection.
An analysis by Vanguard Communications suggests more weight is attached to physician patient reviews compared to those of hotels and restaurants.
Off-label product use is fairly common in aesthetics and plays a key role in advancing treatment practices in the specialty. Dr. Amy Foreman Taub explains the four she uses on a regular basis.